北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第一临床医学院  > 皮肤性病科  > 期刊论文
学科主题: 临床医学
题名:
Botulinum Toxin Type A for the Treatment of Glabellar Lines in Chinese: A Double-Blind, Randomized, Placebo-Controlled Study
作者: Wu, Yan1; Zhao, Guang2; Li, Hengjin3; Zheng, Zhizhong4; Zhong, Shaomin1; Yang, Zhiyong2; Feng, Zheng3; Yang, Qinping4; Zhu, Xuejun1
刊名: DERMATOLOGIC SURGERY
发表日期: 2010
DOI: 10.1111/j.1524-4725.2009.01390.x
卷: 36, 期:1, 页:102-108
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Dermatology ; Surgery
研究领域[WOS]: Dermatology ; Surgery
关键词[WOS]: FROWN LINES ; EXOTOXIN ; RHYTIDS ; EFFICACY ; SAFETY
英文摘要:

BACKGROUND

This is the first well-controlled study of the use of botulinum toxin type A (BoNTA) for glabellar lines in China.

OBJECTIVES

To evaluate the safety and efficacy of BoNTA in the treatment of glabellar lines in Chinese subjects.

MATERIALS AND METHODS

A total of 227 subjects received a single treatment in a 3:1 randomization ratio of BoNTA (20 U):placebo and were observed for 120 days after injection. Effective outcome measures included investigator′s rating of wrinkle severity at maximum frown and rest and subjects′ global assessment and self-perception of age.

RESULTS

A significantly higher responder rate at maximum frown, ranging from 94.1% at day 30 to 52.9% at day 120, was noted in the BoNTA group. The proportion of subjects with none or mild glabellar lines at rest was 66.7% in the BoNTA group at day 30. Most (95.3%) of the subjects treated with BoNTA reported better than 50% improvement at day 30, and self-perception of age was less than chronological age. There were no statistically significant differences in adverse events reported between the two groups (p=.06).

CONCLUSION

A single treatment of 20 U of BoNTA was effective and safe in reducing glabellar lines in Chinese subjects.

GlaxoSmithKline provided funding and study material.

语种: 英语
WOS记录号: WOS:000272892400016
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/51951
Appears in Collections:北京大学第一临床医学院_皮肤性病科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Peking Univ, Hosp 1, Dept Dermatol, Beijing 100034, Peoples R China
2.Gen Hosp AF, Dept Dermatol, Beijing, Peoples R China
3.Chinese Peoples Liberat Army Gen Hosp, Dept Dermatol, Beijing, Peoples R China
4.Fudan Univ, Dept Dermatol, Huashan Hosp, Shanghai 200433, Peoples R China

Recommended Citation:
Wu, Yan,Zhao, Guang,Li, Hengjin,et al. Botulinum Toxin Type A for the Treatment of Glabellar Lines in Chinese: A Double-Blind, Randomized, Placebo-Controlled Study[J]. DERMATOLOGIC SURGERY,2010,36(1):102-108.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Wu, Yan]'s Articles
[Zhao, Guang]'s Articles
[Li, Hengjin]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Wu, Yan]‘s Articles
[Zhao, Guang]‘s Articles
[Li, Hengjin]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace